Request Demo
Last update 23 Jan 2025
JKN2403
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PREP inhibitors(Prolyl endopeptidase inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with JKN2403CTR20244878
评价JKN2403片在中国健康受试者中单次给药安全性、耐受性和药代动力学的一项随机、双盲、安慰剂对照、剂量递增的Ia期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation Phase Ia clinical study to evaluate the safety, tolerability and pharmacokinetics of a single dose of JKN2403 tablets in healthy Chinese subjects
100 Clinical Results associated with JKN2403
Login to view more data
100 Translational Medicine associated with JKN2403
Login to view more data
100 Patents (Medical) associated with JKN2403
Login to view more data
100 Deals associated with JKN2403
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Phase 1 | CN | 30 Dec 2024 | |
| Moderate chronic obstructive pulmonary disease | IND Approval | CN | 19 Dec 2024 | |
| Severe chronic obstructive pulmonary disease | IND Approval | CN | 19 Dec 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free